Zurich Insurance Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3M | Sell |
52,372
-157,534
| -75% | -$70.1M | 0.18% | 108 |
|
|
2025
Q1 | $102M | Buy |
209,906
+158,379
| +307% | +$76.8M | 0.82% | 37 |
|
|
2024
Q4 | $20.7M | Sell |
51,527
-1,735
| -3% | -$699K | 0.17% | 122 |
|
|
2024
Q3 | $24.8M | Sell |
53,262
-38,056
| -42% | -$17.7M | 0.21% | 112 |
|
|
2024
Q2 | $42.8M | Buy |
+91,318
| New | +$42.8M | 0.37% | 78 |
|
|
2024
Q1 | – | Sell |
-185,815
| Closed | -$75.6M | – | 292 |
|
|
2023
Q4 | $75.6M | Sell |
185,815
-50,359
| -21% | -$20.5M | 0.77% | 43 |
|
|
2023
Q3 | $82.1M | Sell |
236,174
-59,758
| -20% | -$20.8M | 0.87% | 32 |
|
|
2023
Q2 | $104M | Buy |
+295,932
| New | +$104M | 1.08% | 25 |
|
|
2019
Q4 | – | Sell |
-46,850
| Closed | -$7.94M | – | 477 |
|
|
2019
Q3 | $7.94M | Buy |
46,850
+1,554
| +3% | +$263K | 0.15% | 167 |
|
|
2019
Q2 | $8.31M | Buy |
45,296
+1,779
| +4% | +$326K | 0.16% | 175 |
|
|
2019
Q1 | $8.01M | Sell |
43,517
-31,257
| -42% | -$5.75M | 0.17% | 171 |
|
|
2018
Q4 | $12.4M | Buy |
74,774
+2,412
| +3% | +$400K | 0.3% | 101 |
|
|
2018
Q3 | $13.9M | Buy |
72,362
+33,572
| +87% | +$6.47M | 0.3% | 100 |
|
|
2018
Q2 | $6.59M | Sell |
38,790
-15,357
| -28% | -$2.61M | 0.15% | 204 |
|
|
2018
Q1 | $8.83M | Buy |
54,147
+16,644
| +44% | +$2.71M | 0.2% | 134 |
|
|
2017
Q4 | $5.62M | Buy |
37,503
+4,603
| +14% | +$690K | 0.13% | 185 |
|
|
2017
Q3 | $5M | Sell |
32,900
-4,433
| -12% | -$674K | 0.14% | 182 |
|
|
2017
Q2 | $4.81M | Sell |
37,333
-8,268
| -18% | -$1.07M | 0.14% | 181 |
|
|
2017
Q1 | $4.99M | Sell |
45,601
-2,209
| -5% | -$242K | 0.14% | 175 |
|
|
2016
Q4 | $3.52M | Buy |
47,810
+5,181
| +12% | +$382K | 0.11% | 233 |
|
|
2016
Q3 | $3.72M | Buy |
42,629
+26,534
| +165% | +$2.31M | 0.12% | 201 |
|
|
2016
Q2 | $1.38M | Buy |
+16,095
| New | +$1.38M | 0.05% | 299 |
|